Course Description:

Module Aims:

The aims of this module are to enable students to develop an advanced knowledge in applied therapeutics relevant to the management of specified cardiovascular diseases, renal and hepatic diseases and diabetes.

Deal with complex patient care issues both systematically and creatively, make reasoned clinical judgements judgments in the absence of complete data and communicate their conclusions clearly to specialist and non-specialist audiences.

Demonstrate their advanced knowledge and systematic understanding of medicines optimisation principles to support patient care across the integrated care system.

Perform at an appropriate level of professional practice in relevant aspects of the Foundation Pharmacy Framework.

Assessment Details:

Coursework 1 (NB. Multiple coursework elements can be structured in Canvas)

• Weighting - 100%
• Pass mark out of 100 - 50%
  

Learning Outcomes:

Knowledge and Understanding

Successful students will typically:

• Demonstrate a deep knowledge and systematic understanding of pharmacotherapeutics related to patients with specified cardiovascular diseases, renal and hepatic diseases and diabetes.
• Demonstrate a systematic understanding of evidence-based approach to medicines optimisation and provision of individualised patient care covering these disease conditions.
• Demonstrate a systematic understanding of policies, pathways, services and resources applicable to patients to support adequate provision of care across the care systems.

Intellectual, Practical and Transferable Skills
Successful students will typically:

• Autonomously adapt performance in relation to the epidemiology, aetiology, pathophysiology and therapeutic management of patients within their scope of practice with specified cardiovascular diseases, renal and hepatic diseases and diabetes.
• Critically evaluate medicines optimisation strategies for patients in their care diagnosed with these diseases states based on the application of relevant theory and evidence based practice.
• Autonomously demonstrate the application of integrated care systems principles in the provision of individualised pharmaceutical and patient care to patients with these disease conditions.
  

Module Content:

This module covers the application of theory, policy and guidelines relevant to the provision of pharmaceutical and patient care services to patients with specified cardiovascular diseases (atrial fibrillation, angina, heart failure and stroke), renal and hepatic diseases (alcoholic liver disease, chronic kidney disease and hepatorenal syndrome) and diabetes (type 1 and type 2).

Case studies reflecting practice across sectors will be used. Students are expected to engage in learning within their workplace to inform and improve their autonomous practice and contributions as part of the multidisciplinary team.

Further Details:

This module provides students with an understanding of the management of patients based on integrated care principles. The learning outcomes of this module will be achieved by a variety of methods including: experiential learning in the workplace facilitated by a work based or academic tutor, independent learning, identification of learning needs related to continuing professional development, independent review of materials available for eLearning, structured reading, problem based learning, seminars and group discussion on study days.

Compulsory Information:

Coursework pass/fail.

Portfolio content Coursework 1.

100% Panel interview based on portfolio content.

All individual elements of assessment must be passed.

Students must achieve the minimum pass criteria for portfolio content in order to undertake the panel interview.

The following elements must be included in the portfolio before the student can progress to the panel interview:

• One Mini Peer Assessment entry where the student must achieve the ‘meets expectation’ grade or above in relevant attribute descriptions.
• Two Mini Clinical Evaluation Exercise entries where the student must achieve the ‘meets expectation’ grade or above in relevant attribute descriptions. 
• One Case Based Discussion entry where the student must achieve the ‘meets expectation’ grade or above in relevant attribute descriptions. 
• One Medication Related Consultation Framework entry (not self-assessed) where the student must achieve the overall ‘satisfactory’ grade or above in relevant attribute descriptions. 
• FOUR Extended Intervention entries (one must be based on social care, one on specified cardiovascular diseases, one on renal/hepatic diseases and one on diabetes) where the student has been signed off for making safe extended interventions.
• One Foundation Pharmacy Framework progress review entry covering specified attributes descriptions, where the student must achieve the ‘meets expectation’ grade or above in relevant attribute descriptions.

In addition students must include their relevant personal particulars and a completed Foundation Pharmacy Framework Evidence Signposting Form. The Record of In Training Assessment Form B and C will provide indication of progress relating to the above elements of assessment.

Delivery:

• Scheduled campus-based activities - 15 hrs
• Scheduled external learning activities/fieldwork, external visits, work-based learning - 100 hrs
• Directed independent study - 20 hrs
• Self-directed independent study - 15 hrs

Programmes on which this module is offered:

HHMPP MSc Pharmacy Practice